SCHEMBL25040974

SCHEMBL25040974

N#C[C@H]1CCCNCC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25040502 1.00
SCHEMBL30917712 1.00
SCHEMBL25040506 1.00
Hydrochloric Acid SCHEMBL31385112 0.98 CXCR4 (0.30)
Hydrochloric Acid SCHEMBL25287231 0.98 CXCR4 (0.30)
SCHEMBL13664827 0.95 SMN1; SMN2 (0.35)
SCHEMBL102903 0.89
Hydrochloric Acid SCHEMBL1513767 0.87
Piperidine SCHEMBL28017265 0.85 ALDH1A1 (0.45)
SCHEMBL1019673 0.80

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023018812-A1 HETEROCYCLIC COMPOUNDS AND METHODS OF USE AMGEN INC. (US) 2023-02-16 WO disclosed